dichlorophenyl)-2-( lH-imidazol-1-ylmethyl) - 1, 3-dioxalan-4-yl]methoxy]phenyl} piperazine) orally active agent with broad-spectrum activity against a variety of yeasts, dermatophytes, and dimorphous fungi (1, 4, 11, 13, 14) .
Chemically, ketoconazole is related to miconazole, an antimycotic agent whose activity may be due in part to alteration of membrane permeability originating from interference with the biosynthesis of ergosterol and the accumulation of sterols with a methyl group at C-14 in the fungal cell (8, 15, 16) .
This study was undertaken in an attempt to define the action of ketoconazole on sterol synthesis in yeast-phase and mycelial-phase Candida albicans cells. The oral effectiveness of ketoconazole makes it possible to study the inhibitory effect of oral ketoconazole on ergosterol synthesis in C. albicans present in the vagina of artificially infected rats.
MATERIALS AND METHODS
In vitro studies: strains, inocula, and media. Three different strains of C. albicans were used. Their selection was based on the fact that they were growing best as yeast (ATCC 28516 = RV 4688) or mycelium (B 12377) or were highly infective to rats (B 2630).
Inocula of C. albicans B 12377 and ATCC 28516 were prepared as previously described (16, 17) . Cells were grown aerobically in a reciprocating shaker at 37°C for 64 h, and 0.2-ml portions were used to inoculate either casein hydrolysate-yeast extract-glucose medium (CYG medium) or keratin medium. Cells were grown for 24 or 72 h at 370C with shaking, and 0.2-nil portions containing 3 x 107 and 2 x 107 cells were used to inoculate 100 ml of CYG or keratin medium, respectively.
Cells were grown in CYG medium for 24 h, and portions (7.5 x 106 cells) were used to inoculate tissue culture dishes or tissue flasks containing 10 or 50 ml of Eagle minimum essential medium (EMEM).
Sabouraud agar, broth, and CYG medium were prepared as previously described (17) .
For keratin-medium (A) 20 g of keratin (Merck, Darmstadt, West Germany) and 1 g of NaOH were dissolved in 300 ml of water in an Erlenmeyer flask which contained 10 g of glass beads (diameter, 5 mm) and was placed on a magnetic stirrer for 20 min.; (B) 23.4 g of yeast carbon base (Difco) was dissolved in 1,700 ml of water. A and B were combined with stirring. The pH was corrected at 7. The suspension was then passed through two Endocott sieves of 45 and 400 mesh and filtered through a Buchner filter (S & S no. 1450). The protein content was determined (12) and corrected to 8.4 mg/ml by dilution with B. The medium was dispensed in 100-ml portions and autoclaved.
EMEM was prepared by the method of Aerts and De Brabander (Mykosen, in press). A 500-ml amount of EMEM (Flow Laboratories, 5023 M) was supplemented with 11.4 ml of sodium bicarbonate (7.5%, Flow, 7-041 D), 6 24 h of growth. Growth, cell collection, and processing were as described above.
(ii) Thin-layer chromatography. The extracted lipids were separated by thin-layer chromatography on precoated silica gel 60F254 plates (Merck no. 5715) using heptane-isopropyl ether-glacial acetic acid, 60: 40:4 (vol/vol/vol), as a solvent system (16) .
(iii) Determination of radioactivity. Bands on the thin-layer chromatographic plate were located by spraying with 50% aqueous sulfuric acid and heating at 150°C until spots cdrresponding to free sterols, free fatty acids, and glycerides appeared. The R/s of the different lipids were compared with those of standards separated with the same solvent system (16) . After detection, the bands were scraped out into plastic counting vials and mixed with 1 ml of water and 10 ml of scintillator solution (Lumagel, Lumac). The radioactivity was determined with a Packard Tri-Carb liquid scintillation spectrometer.
(iv) Identification of sterols. The chemical structures of the sterols present in ketoconazole-treated (10-7 M) or untreated C. albicans (strain ATCC 28516) were determined by gas chromatographic-mass spectrometric analysis (16) .
In vivo studies: animals. Female Wistar rats, weighing 100 g, were ovariectomized and hysterectomized under Thalamonal anaesthesia. Three and four weeks later the rats were treated subcutaneously weekly with 0.1 mg of estradiol in 1 ml of sesame oil. Rats in pseudo-estrus were infected intravaginally with C. albicans (strain B 2630, 8 x 105 cells) on the day of the second estradiol injection.
Treatment. Treatment of the C. albicans-infected rats always started 3 days after infection. At the time of treatment, the rats weighed about 250 g.
Mevalonate incorporation into sterols. One gram of DL-mevalonic acid lactone (Sigma) was dissolved in 8 ml of 0.2 N KOH, and the solution was stored at 37°C. After the solution was cooled to room temperature, its pH was adjusted to 7.3 with 0.1 N KOH and 250 ,uCi of DL-[2-'4C]mevalonic acid dibenzylethylenediamine salt (The Radiochemical Centre, Amersham; specific activity, 51 mCi/mmol) was added. The volume was adjusted to 50 ml with water.
Two hours after treatment with ketoconazole or the excipient or both, rats were injected intraperitoneally with 5 ,uCi of the mevalonate solution. The rats were sacrificed and dissected 2 h later.
The contaminating epithelial cells were disrupted in 0.1 M sodium phosphate buffer at pH 7.4 with a Potter-Elvehjem homogenizer with a Teflon pestle. C. albicans withstands such a homogenization procedure and can be collected by centrifugation for 10 min at 310 x g.
Livers pooled from 14 rats were cut in small pieces, washed twice in 0.1 M sodium phosphate buffer (pH 7.4), resuspended in the same medium, and homogenized with a Potter-Elvehjem homogenizer with Teflon pestle.
The collected C. albicans cells were handled as already described. The lipid content of the liver homogenates was determined by the phosphoric acidvanillin method of Zoilner and Kirsch (19) . The homogenates were diluted to obtain a lipid content of 8.5 mg/5 ml. Extraction and separation of the lipids and determination of radioactivity was essentially the same as that described for C. albicans grown in vitro.
RESULTS
Effects on growth. Inhibition of growth of C. albicans ATCC 28516 occurred within 3 to 5 h after the addition of lo-8 to 10-4 M ketoconazole ( Fig. 1) . At i07 M ketoconazole, 70% inhibition of cell growth was observed after 24 h of contact.
In keratin medium (Fig. 2) Concomitantly, a significantly increased incorporation was noticed in the fractions containing 4,14-dimethyl-and 4,4',14-trimethylsterols.
Examination of the sterol fractions from C. albicans after 16 h of incubation also revealed a shift from 4-desmethylsterols to sterols with methyl groups at C-4 and C-14 ( Fig. 5) . At (0) In EMEM the inoculated C. albicans B 12377 rapidly transformed into mycelial cells (3) . When dry weight of the harvested cells was used as a measure of cell growth, the lag period and exponential growth phase approximated 4 and 20 h (Fig. 3) .
When 1lo8 M ketoconazole was added to C. albicans cultures, little inhibition of growth occurred before 16 h after addition of the antifungal agent. However, 16 or 9 h after the addition of lo-6 or 10-4 M ketoconazole, the rate of dryweight increase was significantly inhibited (Fig.  3) .
The results presented in Table 1 (Fig. 4) . A 50% decrease in acetate incorporation into 4-desime- Table 2 ). The 4-desmethyl fraction collected from control cells consisted of ergosterol, and the small amount of 4,4',14-trimethylsterol was lanosterol.
In cells treated for 16 h with 10-7 M, the 4-desmethylsterol fraction contained 14-methylfecosterol instead of ergosterol; in the 4,14-dimethylsterol fraction, obtusifoliol or 4,14-dimethyl-ergosta-8,24 (28)-dien-3,8-ol was found.
The 4,4',14-trimethylsterol fraction contained lanosterol and a sterol whose mass spectrum was O Ir 0 i0o9 identical with that published for 24-methylenedihydrolanosterol (16) .
The sterol esters isolated from a control culture or from a culture incubated for 16 h in the presence of io-7 M ketoconazole were saponified, and the sterols were separated by gas-liquid chromatography and identified by mass spectrometry. The total ion chromatogram of the control culture showed two major sterol fractions. The mass spectrum of the first eluting sterol corresponded to that of ergosta-7,24 (28)-dien-3,8-ol (episterol). The spectrum of the second major sterol corresponded to that of 4,4',14-trimethylcholesta-8, 24-dien-3,8-ol (lanosterol).
Two minor sterols with a 24-methylene side chain were detected. Complete elucidation of these structures was not possible. Analysis of the sterol fraction obtained from the treated culture showed no evidence of the sterols mentioned above. Three sterols were found. The first eluting sterol could be identified as 14-methylfecosterol, the second was obtusifoliol, and the third was 24-methylenedihydrolanosterol. No ergosterol could be found.
(ii) C. albicans grown in keratin medium. No marked effect was found on the radioactivity present in lipid extracts of C. albicans exposed for the first 4 h of the lag phase to ['4C]acetate and to ketoconazole.
However, between control and ketoconazoletreated cells remarkable differences were evident in the radioactivity incorporated into different sterols (Fig. 6) . The incorporation of acetate into the 4-desmethylsterols was significantly decreased at ketoconazole concentrations o1O-M. Fifty percent inhibition was achieved at 4 x 10'-M. Concomitantly, an increased incorporation of [14C]acetate. was noticed in the fractions containing 4,14-dimethyl-(obtusifoliol) and 4,4',14-trimethylsterols (lanosterol and 24-methylenedihydrolanosterol).
(iii) C. albicans grown in EMEM. Interference of ketoconazole with ergosterol synthesis was also observed when drug was added to media in which the yeast phase of C. albicans transformed to the mycelial phase. Table 3 (-----). Radioactivity was determined in the total lipid fraction, in the ergosterol or cholesterol (0) fraction, and in the fraction containing the 4,14-dimethyl-and 4,4,14-trimethylsterols (x). tion of the ergosterol synthesis was not affected by serum (Table 3) .
Ketoconazole also is a potent inhibitor of the conversion of lanosterol into ergosterol when added to cultures containing outgrown mycelium (Table 4) Fig. 7 , there was a dose-dependent decrease in the radioactivity incorporated into the ergosterol of C. albicans which coincided with increased incorporation of radioactivity into 4,14-dimethyl-and 4,4',14-trimethylsterols (here fractionated together out of the lipid extract). The shift from ergosterol to C-14 methylated sterols was apparent at 0.63 mg/kg, reached the 50% level at 1.7 mg, and was almost complete at 10 mg/kg. At the latter dose there was a 50% decrease in incorporation of radioactivity into cholesterol into rat liver. Thus, as compared with C. albicans, almost six times more ketoconazole is needed to obtain a similar accumulation of radioactivity in C-14 methylated sterols of liver.
DISCUSSION
The experimental evidence presented indicates that the imidazole derivative, ketoconazole, is a potent inhibitor of ergosterol biosynthesis in C. albicans grown in culture media which support yeast or mycelial growth. In all circumstances investigated, the inhibition of ergosterol biosynthesis occurred before any measurable effect on growth. Of great interest is the interference of ketoconazole with ergosterol synthesis in fully developed mycelium, a form mostly encountered in vivo. Low doses of ketoconazole administered orally to rats artificially infected with C. albicans also affect the ergosterol synthesis in Candida. A six-times-higher dose is required to effect cholesterol synthesis by rat liver.
This greater inhibitory effect may be due at least partly to differences in the sterol metabolism of yeast and mammalian cells. Preliminary results indicate that the mevalonate incorporation into ergosterol by a 10,000 x g supernatant fraction of yeast cells is much more sensitive to ketoconazole than the incorporation into cholesterol by a similar fraction isolated from rat liver (manuscript in preparation).
Under all circumstances studied, the ketoconazole-induced inhibition of the ergosterol biosynthesis that coincided with an accumulation of sterols with a methyl group at C-14 can thus be attributed to an interference with one of the reactions involved in the removal of the 14a-methyl group of lanosterol.
Studies of the effects of C-14 methyl sterols on properties of artificial membranes (6, 8, 10, 18) , on growth of anaerobic yeast and certain mutant animal cell lines (5) , and on the developmental process of pupating insects have shown that lanosterol is unable to replace 4-desmethylsterols (e.g., cholesterol) in sterol-requiring eucaryotic cells (2) . For The presence of a 14a-methyl is the principal structural feature responsible for the disparate membrane effects of lanosterol and cholesterol (2) . This was evidenced by studying the properties ofartificial phospholipid vesicles as a function of sterol composition. By using glucose permeability as a parameter, it was shown that the incorporation of cholesterol into lecithin vesicles reduced the release of entrapped glucose from 50 to about 5%. However, when lanosterol replaced cholesterol in the vesicles, the exit of trapped glucose from the vesicles was delayed only slightly (10) .
Based on all these studies, it is reasonable to speculate that the presence of sterols with a methyl group at C-14 in the ketoconazoletreated C. albicans may lead to functional changes in the membranes. Changes in the membranes may be at the origin of permeability changes, leaky membranes, inhibition of growth, and increased susceptibility of the invasive cells to the host defense system.
